<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurol Genet</journal-id>
<journal-id journal-id-type="hwp">nng</journal-id>
<journal-id journal-id-type="publisher-id">NNG</journal-id>
<journal-title-group>
<journal-title>Neurology: Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">2376-7839</issn>
<publisher>
<publisher-name>Wolters Kluwer</publisher-name>
<publisher-loc>Baltimore</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28626794</article-id>
<article-id pub-id-type="pmc">5458666</article-id>
<article-id pub-id-type="publisher-id">NG2016004358</article-id>
<article-id pub-id-type="doi">10.1212/NXG.0000000000000156</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>91</subject>
<subject>120</subject>
<subject>163</subject>
<subject>174</subject>
<subject>176</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Clinical/Scientific Notes</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Febrile ataxia and myokymia broaden the SPG26 hereditary spastic paraplegia phenotype</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dad</surname>
<given-names>Rubina</given-names>
</name>
<degrees>MPhil</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walker</surname>
<given-names>Susan</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scherer</surname>
<given-names>Stephen W.</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>Scientific Advisory Board of Population Diagnostics</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>(1) npj Genomic Medicine, Senior Editor, 2015-present (2) G3: Genes, Genomes, Genetics, Senior Editor, 2011- present (3) Journal of Personalized Medicine, Editorial Board, 2010-Present (4) The Open Genomics Journal, Editorial Advisory Board, 2009-present (5) The Hugo Journal, Editorial Board, 2009-present (6) Genome Medicine, Editorial Board, 2008-present (7) Journal of Neurodevelopmental Disorders, Section Editor, 2008-present (8) Autism Research, Editorial Board, 2008-present (9) PathoGenetics, Editorial Board, 2008-present (10) Comparative and Functional Genomics, Editorial Board, 2007-present (11) BMC Medical Genomics, Editorial Board, 2006-present (12) Cytogenetics and Genome Research, Editorial Board, 2005-present</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>(1) Genome Canada/ Ontario Genomics Institute (2) Canadian Institutes of Health Research (3) Canadian Institute for Advanced Research (4) McLaughlin Centre (5) Canada Foundation for Innovation (6) government of Ontario (7) NIH</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>Autism Speaks SickKids Foundation</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hassan</surname>
<given-names>Muhammad Jawad</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alghamdi</surname>
<given-names>Mohammad Domaia</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Minassian</surname>
<given-names>Berge A.</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>Patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, VMA21</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number P01 NS097197</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License fee payments, Technology or Inventions:</title>
<list-item>
<p>From patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, VMA21</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>From patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, VMA21</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Alkhater</surname>
<given-names>Reem A.</given-names>
</name>
<degrees>MD, FRCP (C), MSc</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<aff>From the Atta-ur Rahman School of Applied Biosciences (R.D., M.J.H.), National University of Sciences and Technology (NUST), Pakistan; Program in Genetics and Genome Biology (R.D., B.A.M.), Division of Neurology (B.A.M.), Department of Paediatrics, and The Centre for Applied Genomics, Genetics and Genome Biology (S.W., S.W.S.), The Hospital for Sick Children; Department of Molecular Genetics (S.W.S.), and McLaughlin Centre (S.W.S.), University of Toronto, Ontario, Canada; and Department of Pediatrics (M.D.A., R.A.A.), Division of Neurology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence to Dr. Alkhater: <email>Reem.khater@jhah.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>5</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>3</volume>
<issue>3</issue>
<elocation-id>e156</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American Academy of Neurology</copyright-holder>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND)</ext-link>, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</license-p>
</license>
</permissions>
<self-uri xlink:href="NG2016004358.pdf" xlink:title="pdf"></self-uri>
<custom-meta-group>
<custom-meta>
<meta-name>OPEN-ACCESS</meta-name>
<meta-value>TRUE</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body><p>Hereditary spastic paraplegias (SPGs) are among the genetically most diverse neurologic disorders with over 70 loci identified.<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup> The recessively inherited SPG26 is caused by mutations in <italic>B4GALNT1</italic>, encoding the β-1-4-N-acetyl-galactosaminyl transferase which functions in the biosynthesis of complex glycosphingolipids. To date, 12 families have been reported in 3 publications, with a broad phenotypic spectrum within and between families (<xref ref-type="table" rid="T1">table 1</xref>). We add a new family to the literature with 3 affected members and a remarkable phenotype of purely fever-induced ataxia with myokymia. We also review all published cases<sup><xref ref-type="bibr" rid="R3">3</xref><xref ref-type="bibr" rid="R4">–</xref><xref ref-type="bibr" rid="R5">5</xref></sup> to encapsulate the current knowledge of the neurologic features and spectrum of this disease.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of clinical features of all published cases with <italic>B4GALNT1</italic> mutations (NM_001478)</p></caption><graphic xlink:href="NG2016004358TT1"></graphic></table-wrap><p>Our proband presented at age 5 years with severe fever-induced ataxia and myokymia, the latter in the flexor muscles of the hands and feet, which additionally exhibited carpopedal spasm. Presumed postviral cerebellitis, he was treated with methylprednisolone and IV immunoglobulin and recovered fully in a week. He had 4 additional identical episodes until age 10, all induced by a febrile illness (39–40°C), each self-resolving, untreated, following defervescence. Examination at age 11 shows proximal muscle weakness, mild lower limb spasticity, preserved deep tendon reflexes and sensation, intact cognition, normal brain MRI, and evidence of peripheral neuropathy on nerve conduction study. His parents are first-degree cousins, and he has 2 older sisters and 1 older brother. The sisters are lean and tall with relative microcephaly, and on examination have reduced muscle bulk, proximal muscle weakness, and mildly spastic gait. The elder sister had had Achilles tendon release surgery at age 8 but continued to have lower limb spasticity. Her and affected brother's Spastic Paraplegia Rating Scale scores were 4/52 and 13/52, respectively (tables e-1 and e-2 at <ext-link ext-link-type="doi" xlink:href="10.1212/NXG.0000000000000156">Neurology.org/ng</ext-link>). The older brother was and remains healthy. Whole-exome sequencing (e-Methods) for proband and 1 sister revealed a single significant shared homozygous variant, namely <italic>B4GALNT1</italic> chr12:58021427:G&gt;C; NM_001478: c.C1358G; p.Pro453Arg. No other known SPG, myokymia, or ataxia-related genes harbored clinically relevant variants (table e-3). Sanger sequencing in all family members confirmed that the <italic>B4GALNT1</italic> change was homozygous in proband and sisters and heterozygous in healthy brother and parents. It was not present in the 1000 Genomes European, American, Asian, or African databases, dbSNP or ExAC. The variant was predicted damaging by PolyPhen2 and CADD and evolutionarily conserved (PhyloP). No further functional consequences could be predicted.</p><p>A summary of all SPG26 published cases (<xref ref-type="table" rid="T1">table 1</xref>) reveals spastic paraparesis as a commonly shared core symptom. The disease extends to other systems and includes dysarthria, ataxia, intellectual disability, and psychiatric manifestations, none of which is uniformly present across families and even within families. Onset is in childhood, usually before age 10, in all families except 1, with a missense mutation and onset between 28 and 39 years. In this family, despite late onset, progression was rapid, with severe muscle wasting.<sup><xref ref-type="bibr" rid="R3">3</xref></sup> Our family, with another missense mutation, appears to be the mildest to date among childhood-onset cases, and the phenotype is particularly mild in the 2 girls (<xref ref-type="table" rid="T1">table 1</xref>). They had a later age at onset than the boy (8 vs 5), and, despite being older (15 and 21 vs 11), have no muscle wasting or ataxia and only mild spasticity. Finally, the male patient manifests a symptom set not previously reported, namely febrile ataxia and myokymia with full recovery after each attack.</p><p>Complex glycosphingolipids (e.g., GM1 or GD1a gangliosides) are crucial components of plasma membranes but are by far most abundant in nervous tissue. Their 2 principal roles are to mediate cell-cell interactions and regulate membrane protein functions. Additional functions include endocytosis, signal transduction, and synaptic plasticity. Complex glycosphingolipids represent a family of many molecules, the shared “glyco” component consisting of 4 glucans serially added to the sphingolipid during biosynthesis. B4GALNT1 catalyzes the addition of the third (N-acetyl-β-<sc>d</sc>-galactosamine) to the second glucan, and the absence of the enzyme results in nonprogression to the more complex forms (e.g., from GM3 to GM2 and GM1).<sup><xref ref-type="bibr" rid="R6">6</xref></sup>
<italic>B4galnt1</italic> knockout mice are healthy, suggesting that shorter gangliosides (e.g., GM3) largely compensate for absent longer forms.<sup><xref ref-type="bibr" rid="R7">7</xref></sup> This appears to be the case also in humans, as evidenced by the patients discussed here, but only for the years until disease onset. After that, there is progressive neurologic decompensation. Precisely, which complex ganglioside deficiency(ies) in which cell types, regions or pathways underlie the upper and lower motor neuron disease and other aspects of SPG26 await future studies. This knowledge will help elucidate the roles of complex glycosphingolipids in the development and function of the central and peripheral nervous systems.</p>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Data Supplement</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_3_3_e156__index.html"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_3.3.e156_e-Methods.docx" xlink:role="associated-file"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_3.3.e156_Table_e-1.docx" xlink:role="associated-file"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_3.3.e156_Table_e-2.docx" xlink:role="associated-file"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_3.3.e156_Table_e-3.docx" xlink:role="associated-file"></media>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supplementary-material">
<p>Supplemental data at <ext-link ext-link-type="doi" xlink:href="10.1212/NXG.0000000000000156">Neurology.org/ng</ext-link></p>
</fn>
<fn fn-type="other">
<p><italic>Author contributions: Study concept and design by Berge A. Minassian and Reem A. Alkhater. Acquisition of clinical data by Reem A. Alkhater and Mohammad Domaia Alghamdi. Acquisition of data by Susan Walker and Stephen W. Scherer. Analysis and interpretation of data by Rubina Dad and Susan Walker</italic>. <italic>Study supervision by Berge A. Minassian, Reem A. Alkhater, and Muhammad Jawad Hassan. Critical revision of manuscript for intellectual content, coinvestigators: Berge A. Minassian, Reem A. Alkhater, and Mohammad Domaia Alghamdi.</italic></p>
</fn>
<fn fn-type="financial-disclosure">
<p>Study funding: No targeted funding reported.</p>
</fn>
<fn fn-type="financial-disclosure">
<p><italic>Disclosure: Rubina Dad, Susan Walker, Muhammad Jawad Hassan, Mohammad Domaia Alghamdi, and Reem A. Alkhater report no disclosures. Stephen Scherer has served on the scientific advisory board of Population Diagnostics; has served on the editorial boards of</italic> Genomic Medicine<italic>,</italic> Genes, Genomes, Genetics<italic>,</italic> Journal of Personalized Medicine<italic>,</italic> The Open Genomics Journal<italic>,</italic> The Hugo Journal<italic>,</italic> Genome Medicine<italic>,</italic> the Journal of Neurodevelopmental Disorders<italic>,</italic> Autism Research<italic>,</italic> PathoGenetics<italic>,</italic> Comparative and Functional Genomics<italic>,</italic> BMC Medical Genomics<italic>, and</italic> Cytogenetics and Genome Research<italic>; and has received research support from Genome Canada/Ontario Genomics Institute, Canadian Institutes of Health Research, Canadian Institute for Advanced Research, McLaughlin Centre, Canada Foundation for Innovation, government of Ontario, NIH, Autism Speaks, and SickKids Foundation. Berge A. Minassian holds patents for diagnostic testing of the following genes: EPM2A, EPM2B, MECP2, and VMA21; receives license fee payments/royalty payments for aforementioned patents; and has received research support from National Institute of Neurological Disorders and Stroke of the NIH. Go to</italic>
<ext-link ext-link-type="doi" xlink:href="10.1212/NXG.0000000000000156"><italic>Neurology.org/ng</italic></ext-link>
<italic>for full disclosure forms. The Article Processing Charge was funded by the authors.</italic></p>
</fn>
</fn-group>
<ack>
<p>Acknowledgment: The authors thank the family members for participation in the study. Rubina Dad acknowledges her funding by the Higher Education Commission of Pakistan under the International Research Support Initiative Program (HEC-IRSIP).</p>
</ack>
<ref-list>
<ref id="R1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noreau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dion</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Rouleau</surname><given-names>GS</given-names></name></person-group>
<article-title>Molecular aspects of hereditary spastic paraplegias</article-title>. <source/>Exp Cell Res
<year>2014</year>;<volume>325</volume>:<fpage>18</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">24631291</pub-id></mixed-citation>
</ref>
<ref id="R2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chrestian</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dupré</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gan-Or</surname><given-names>Z</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical and genetic study of hereditary spastic paraplegia in Canada</article-title>. <source/>Neurol Genet
<year>2016</year>;<volume>3</volume>:<fpage>e122</fpage>
<ext-link ext-link-type="uri" xlink:href="http://ng.neurology.org/lookup/doi/10.1212/NXG.0000000000000122">doi: 10.1212/NXG.0000000000000122</ext-link>.<pub-id pub-id-type="pmid">27957547</pub-id></mixed-citation>
</ref>
<ref id="R3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harlalka</surname><given-names>GV</given-names></name>, <name name-style="western"><surname>Lehman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chioza</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis</article-title>. <source/>Brain
<year>2013</year>;<volume>136</volume>:<fpage>3618</fpage>–<lpage>3624</lpage>.<pub-id pub-id-type="pmid">24103911</pub-id></mixed-citation>
</ref>
<ref id="R4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boukhris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schule</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Loureiro</surname><given-names>JL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia</article-title>. <source/>Am J Hum Genet
<year>2013</year>;<volume>93</volume>:<fpage>118</fpage>–<lpage>123</lpage>.<pub-id pub-id-type="pmid">23746551</pub-id></mixed-citation>
</ref>
<ref id="R5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakil</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Monies</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ramzan</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia</article-title>. <source/>Clin Genet
<year>2014</year>;<volume>86</volume>:<fpage>500</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="pmid">24283893</pub-id></mixed-citation>
</ref>
<ref id="R6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnaar</surname><given-names>RL</given-names></name></person-group>
<article-title>Brain gangliosides in axon-myelin stability and axon regeneration</article-title>. <source/>FEBS Lett
<year>2010</year>;<volume>584</volume>:<fpage>1741</fpage>–<lpage>1747</lpage>.<pub-id pub-id-type="pmid">19822144</pub-id></mixed-citation>
</ref>
<ref id="R7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takamiya</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Furukawa</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system</article-title>. <source/>Proc Natl Acad Sci USA
<year>1996</year>;<volume>93</volume>:<fpage>10662</fpage>–<lpage>10667</lpage>.<pub-id pub-id-type="pmid">8855236</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>